pharmaceutical prices

Oregon Lawmakers Mull Changes To Strengthen Drug Transparency Program 

This article is for premium subscribers. Please sign up here for a tax-deductible subscription. 

If you're a premium subscriber, sign in below. 

Oregon lawmakers are considering changes to the state’s drug transparency law that would prevent pharmaceutical manufacturers from exploiting a potential loophole to avoid reporting price hikes and give state regulators more authority to expect timely information from drug companies.

Subscribe to pharmaceutical prices